Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference March 10, 2021August 16, 2022
Alterity raises $35M in placement to international and Australian institutions and sophisticated investors. October 16, 2020August 16, 2022
Pre-clinical evidence demonstrates PBT434 as a potential treatment for MSA October 5, 2018August 16, 2022